You are here

Company Monitoring Page for Lundbeck

latest headlines for company on cafepharma

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash

Endpoints

Mon, 09/11/17 - 10:20 am

Tags:

Teva Pharmaceutical, Lundbeck, Pharma CEOs, Kåre Schultz

23andMe, Lundbeck unveil mega investigation of genetics' role in depression

BioPharma Dive

Thu, 08/3/17 - 10:58 am

Tags:

23andMe, Lundbeck, genetics, bipolar disorder, major depressive disorder

Tapping into the rare disease market

BioPharma Dive

Fri, 03/10/17 - 09:00 pm

Tags:

Rare Diseases, Incyte, Horizon Pharma, Lundbeck

Lundbeck reads last rites on another failed PhIII Alzheimer’s program

Endpoints

Wed, 02/8/17 - 09:26 am

Tags:

Lundbeck, Otsuka, Alzheimer's disease, idalopirdine

Drug maker loses appeal of antitrust pay-to-delay case in Europe

Stat/Pharmalot

Fri, 09/9/16 - 10:23 am

Tags:

pay-for-delay, Lundbeck, Europe, antidepressants

FDA rejects bid to market antidepressant to treat foggy thinking

Stat

Tue, 03/29/16 - 11:17 am

Tags:

Takeda, Lundbeck, FDA, antidepressants, Brintellix

Why ViiV Healthcare leads the pharma industry in corporate reputation

BioPharma Dive

Wed, 03/23/16 - 04:23 pm

Tags:

ViiV Healthcare, Pfizer, GSK, Shionogi, AbbVie, Lundbeck, Janssen, Novo Nordisk

FDA panel backs game-changing cognitive claim for Lundbeck antidepressant Brintellix

Fierce Pharma

Thu, 02/4/16 - 09:17 pm

Tags:

FDA, antidepressants, Lundbeck, Brintellix

This antidepressant may be no better than cheaper alternatives. But demand could soon soar

Stat

Tue, 02/2/16 - 10:28 am

Tags:

antidepressants, Lundbeck, Takeda Pharmaceuticals, Brintellix

Lundbeck to advance schizophrenia drug solo after taking an ax to early-stage pipeline

Fierce Biotech

Thu, 08/20/15 - 09:14 am

Tags:

Lundbeck, schizophrenia, Lu AF35700

Troubled Lundbeck targets 1,000 layoffs in HQ, commercial revamp

Fierce Pharma

Wed, 08/19/15 - 09:11 am

Tags:

Lundbeck, layoffs, reorganization

FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia

BioPharma Dive

Mon, 07/13/15 - 09:51 am

Tags:

FDA, Otsuka, Lundbeck, schizophrenia, Rexulta

FDA approves Otsuka and Lundbeck's schizophrenia treatment

Yahoo/Reuters

Fri, 07/10/15 - 10:53 pm

Tags:

FDA, Otsuka, Lundbeck, schizophrenia, Rexulti, antipsychotics

Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs

Forbes

Thu, 06/18/15 - 11:03 am

Tags:

clinical depression, Brintellix, Lundbeck

Former Novo exec Schultz will become a CEO after all—just at another pharma

BioPharma Dive

Thu, 05/7/15 - 11:00 am

Tags:

Novo Nordisk, Pharma CEOs, Lundbeck, Kåre Schultz

11 promising drugs poised to be the next billion-dollar blockbusters

Yahoo/Business Insider

Sat, 03/28/15 - 10:26 am

Lundbeck pulls the plug on its fast-tracked stroke drug

Fierce Biotech

Thu, 12/18/14 - 10:25 am

Tags:

Lundbeck, stroke, desmoteplase

Lundbeck CEO Leaves After Failing to Report Receiving Shares

Bloomberg

Mon, 11/24/14 - 09:43 am

Tags:

Lundbeck, Pharma CEOs, Ulf Wiinberg

Avanir Inroads in Alzheimer’s Justify Offers: Real M&A

Bloomberg

Thu, 10/30/14 - 12:22 pm

Tags:

M&A, Avanir, Alzheimer's disease, Lundbeck, Eli Lilly, Mallinckrodt, Shire

Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year

Yahoo

Tue, 06/24/14 - 10:26 am

Tags:

Lundbeck, Chelsea Therapeutics, Northera, neurogenic orthostatic hypotension

Pages

last 30 twitter posts